FDA APPROVES SQUALENE IN FLU SHOT (Nov. 2015)
Squalene was in the Anthrax Vaccine that caused the Gulf War Syndrome to our USA serviceman.
VACCINE SYNDROME– Scott Miller- director/ Writer
Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U.S. vaccine, despite its history of use in other countries
Pandremix vaccine contains 10,68 mg of squalene per 0,5 ml. Only unadjuvanted vaccines are being used in the United States during the 2009 flu season. Pandremix vaccine, a European Vaccine, did contain squalene causing NARCOLEPSY.
The MF-59 adjuvant has been used in several vaccines. These vaccines, including tetanus and diphtheria, are the same vaccines frequently associated with adverse reactions. READ MORE…
VLA COMMENT: FLUAD PEDIATRIC with Squalene is being used in Canada based on literature review of experiments on the elderly 65 & older of which FLUAD is FDA approved. No doubt after experiments are done on infants and children in other countries, it will come to USA.